Patent Assignment
Reel/Frame 049608/0736
Assignment of Assignor's Interest
Recorded: 2019-06-27
Pages: 5
Assignor
RITTER, GERD
Executed: 2016-06-06
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
STADELHOFERSTRASSE 22, ZURICH, 8001, SWITZERLAND
Covered Property
(1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 27, 2019
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 049608/0870 →
Assignment of Assignor's Interest
Jun 27, 2019
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 049608/0629 →
Assignment of Assignor's Interest
Jun 27, 2019
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 049608/0824 →
Assignment of Assignor's Interest
Jun 27, 2019
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 049608/0900 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest
Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →